Anticomplement therapy
Prathit A Kulkarni1, Vahid Afshar-Kharghan21Baylor College of Medicine, Houston, Texas, USA; 2The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USAAbstract: The complement system is an important part of innate immunity; however, as with other parts of the immune system, the compl...
Guardado en:
Autores principales: | Prathit A Kulkarni, Vahid Afshar-Kharghan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2270e7b75e2d4967945be6dff192830e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted therapy in melanoma
por: Hussein Tawbi, et al.
Publicado: (2009) -
Targeted therapy for sarcomas
por: Forscher C, et al.
Publicado: (2014) -
Customization of therapy for gastroesophageal adenocarcinoma patients
por: Dilsa Mizrak Kaya, et al.
Publicado: (2018) -
Targeting MET in cancer therapy
por: Hong-Nan Mo, et al.
Publicado: (2017) -
Clinical significance of metallothioneins in cell therapy and nanomedicine
por: Sharma S, et al.
Publicado: (2013)